MENLO PARK, Calif.--(BUSINESS WIRE)--Ionpath, a leader in high-definition spatial proteomics, today announced the launch of MIBIslide™ Blue, a groundbreaking advancement in multimodal imaging.

PLEASANTON, Calif. and PARIS, Nov. 6, 2023 /PRNewswire/ -- OWKIN and 10x Genomics, Inc. (TXG), announce they have entered into an agreement to add 10x Genomics spatial omics and single-cell ...

Advanced deep learning (DL) and large language models (LLMs) decode multimodal imaging-omics associations across modalities, scales, organs, and diseases. The framework enables interpretable analysis ...

This article and associated images are based on a poster originally authored by Matthew Chung, William Guesdon, Kai Lawson-McDowall and Matthew Alderdice and presented at ELRIG Drug Discovery 2025 in ...

Premalignant lesions serve as critical transitional states in the development of many cancers. They also provide a scientific basis for the traditional Chinese medicine (TCM) concept of “treating ...

Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., FMedSci, Candel’s President and CEO, will present the phase 3 ...

Novigenix, a leader in AI-driven healthcare solutions, has published a groundbreaking study showcasing the predictive power of its LITOSeek ™ platform for immunotherapy response in metastatic ...

SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of BioInsight, a new business within Illumina, developed to meet industry demand for deeper biologic ...

The "Spatiotemporal Omics Market - A Global and Regional Analysis: Focus on Technology, Application, End User, and Country - Analysis and Forecast, 2025-2035" report has been added to ...